A Multi-Dimensional Comparative Study of 505(b)(2) NDAs Approved by FDA and Class 2 NDAs Approved by NMPA from 2017 to 2023: Uncovering Trends, Characteristics, and Regulation of Modified New Drugs.
Regulatory toxicology and pharmacology RTP（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined